Return to site

Allergy Diagnostics Market Size, Industry Analysis, and Forecast

The Global Allergy Diagnostics Market is expected to reach $ 5.74, at a CAGR of 10.5%

· Medical Devices

The high incidence of allergic diseases is one of the major factors driving the growth of this Allergy Diagnostics Market. the high incidence and large economic burden of allergic diseases, rising environmental pollution levels, increasing healthcare expenditure, and growing access to medical insurance in the US are expected to drive the growth of this market.

Allergy Diagnostics Market

The rising environmental pollution levels and the growing need for relatively faster, accurate, and high-throughput technologies for allergy diagnostics are the major factors supporting the growth of this Allergy Diagnostics Market.

Allergy Diagnostics Market segmentation:

· based on product & service.

· based on test type.

· based on allergen.

· based on end users.

· based on regions.

The Major Players Operating in the Allergy Diagnostics Market:

Major industry players launched innovative products in the recent past and have plans to launch new products and expand across geographies via partnerships and acquisitions in the future.

Key players in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE — Achterrath Laboratorien GmbH (Germany).

Further, these leaders have products for all end users in this segment, strong geographical presence, and more importantly focus on continuous product innovations.

Geographical Detailed Analysis for Allergy Diagnostics Market:

North America estimated to account for the major market share in 2017.

Based on the region, the allergy diagnostics market is segmented into North America, Europe, Asia, and the Rest of the World (Row).

In 2017, North America is expected to command the largest share of the allergy diagnostics market.

The large share of this segment can primarily be attributed to the increasing healthcare expenditure, coverage of allergy diagnostics tests in medical insurance, and the strong presence of players in this region.

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly